506 related articles for article (PubMed ID: 18515791)
21. Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a.
Westhoff JH; Hilgers KF; Steinbach MP; Hartner A; Klanke B; Amann K; Melk A
Hypertension; 2008 Jul; 52(1):123-9. PubMed ID: 18504326
[TBL] [Abstract][Full Text] [Related]
22. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats.
Wang DS; Xie HH; Shen FM; Cai GJ; Su DF
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):545-52. PubMed ID: 16026514
[TBL] [Abstract][Full Text] [Related]
23. Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice.
Hartner A; Cordasic N; Klanke B; Veelken R; Hilgers KF
Nephrol Dial Transplant; 2003 Oct; 18(10):1999-2004. PubMed ID: 13679473
[TBL] [Abstract][Full Text] [Related]
24. Pentosan polysulfate preserves renal microvascular P2X1 receptor reactivity and autoregulatory behavior in DOCA-salt hypertensive rats.
Guan Z; Singletary ST; Cha H; Van Beusecum JP; Cook AK; Pollock JS; Pollock DM; Inscho EW
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F456-65. PubMed ID: 26697978
[TBL] [Abstract][Full Text] [Related]
25. Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats.
Nakano D; Itoh C; Ishii F; Kawanishi H; Takaoka M; Kiso Y; Tsuruoka N; Tanaka T; Matsumura Y
Biol Pharm Bull; 2003 Dec; 26(12):1701-5. PubMed ID: 14646174
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage.
Seifi B; Kadkhodaee M; Karimian SM; Zahmatkesh M; Xu J; Soleimani M
Clin Exp Hypertens; 2010 Jan; 32(2):90-7. PubMed ID: 20374182
[TBL] [Abstract][Full Text] [Related]
27. Reduction of kidney damage by supplementation of vitamins C and E in rats with deoxycorticosterone-salt-induced hypertension.
Seifi B; Kadkhodaee M; Karimian SM; Zahmatkesh M; Shams S; Bakhshi E
Iran J Kidney Dis; 2009 Oct; 3(4):197-202. PubMed ID: 19841522
[TBL] [Abstract][Full Text] [Related]
28. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.
Ni W; Fink GD; Watts SW
J Pharmacol Exp Ther; 2007 May; 321(2):485-91. PubMed ID: 17289838
[TBL] [Abstract][Full Text] [Related]
29. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
Kawarazaki H; Ando K; Nagae A; Fujita M; Matsui H; Fujita T
Nephrol Dial Transplant; 2010 Sep; 25(9):2879-89. PubMed ID: 20466668
[TBL] [Abstract][Full Text] [Related]
30. Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
Loch D; Levick S; Hoey A; Brown L
J Cardiovasc Pharmacol; 2006 Mar; 47(3):396-404. PubMed ID: 16633082
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of estradiol in the brain of rats with genetic or mineralocorticoid-induced hypertension.
Pietranera L; Saravia FE; Roig P; Lima A; De Nicola AF
Psychoneuroendocrinology; 2008 Apr; 33(3):270-81. PubMed ID: 18164826
[TBL] [Abstract][Full Text] [Related]
32. Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination.
Piecha G; Koleganova N; Gross ML; Geldyyev A; Adamczak M; Ritz E
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F137-44. PubMed ID: 18434388
[TBL] [Abstract][Full Text] [Related]
33. Concurrent administration of aqueous Azadirachta indica (neem) leaf extract with DOCA-salt prevents the development of hypertension and accompanying electrocardiogram changes in the rat.
Obiefuna I; Young R
Phytother Res; 2005 Sep; 19(9):792-5. PubMed ID: 16220573
[TBL] [Abstract][Full Text] [Related]
34. Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats.
Van den Berg DT; de Kloet ER; de Jong W
Am J Physiol; 1994 Dec; 267(6 Pt 1):E927-33. PubMed ID: 7810636
[TBL] [Abstract][Full Text] [Related]
35. Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats. Comparative study with verapamil.
Galisteo M; García-Saura MF; Jiménez R; Villar IC; Wangensteen R; Zarzuelo A; Vargas F; Duarte J
Planta Med; 2004 Apr; 70(4):334-41. PubMed ID: 15095149
[TBL] [Abstract][Full Text] [Related]
36. Abnormalities of the hippocampus are similar in deoxycorticosterone acetate-salt hypertensive rats and spontaneously hypertensive rats.
Pietranera L; Saravia F; Gonzalez Deniselle MC; Roig P; Lima A; De Nicola AF
J Neuroendocrinol; 2006 Jun; 18(6):466-74. PubMed ID: 16684136
[TBL] [Abstract][Full Text] [Related]
37. Spironolactone inhibits the activity of the Na+/H+ exchanger in the aorta of mineralocorticoid-induced hypertensive rats.
Carreño JE; Verdugo FJ; Contreras F; Montellano FA; Veloso S; Schalper KA; Sandoval M; Villanueva S; Marusic E; Irarrazabal CE
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1225-31. PubMed ID: 25997821
[TBL] [Abstract][Full Text] [Related]
38. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
39. The antihypertensive effect of taurine in DOCA-salt rats.
Fujita T; Sato Y
J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
[TBL] [Abstract][Full Text] [Related]
40. Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism.
Karatas A; Hegner B; de Windt LJ; Luft FC; Schubert C; Gross V; Akashi YJ; Gürgen D; Kintscher U; da Costa Goncalves AC; Regitz-Zagrosek V; Dragun D
Hypertension; 2008 Apr; 51(4):1177-83. PubMed ID: 18259006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
